InvestorsHub Logo
Followers 253
Posts 17999
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Thursday, 08/26/2021 5:18:43 PM

Thursday, August 26, 2021 5:18:43 PM

Post# of 4867
https://finance.yahoo.com/news/gilead-sciences-wins-reversal-1-154757453.html

"... A U.S. appeals court on Thursday threw out a $1.2 billion ruling against Gilead Sciences Inc, finding a patent on a cancer therapy it was accused of infringing was invalid, in a blow to rival Bristol Myers Squibb Co.

The two companies have been embroiled in a case involving accusations that Yescarta, the CAR-T cell cancer immunotherapy from Gilead's Kite Pharma unit, infringed on a patent for a similar therapy from Bristol's Juno Therapeutics.

Last year, a federal judge increased the damages from a jury trial and ordered Gilead to pay Bristol Myers $1.2 billion in the patent infringement case. The ruling on Thursday by the U.S. Court of Appeals for the Federal Circuit reversed the decision.

Bristol Myers in a statement said it disagreed with latest ruling and would seek a review of the Federal Circuit’s decision."

http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1758.OPINION.8-26-2021_1825257.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News